| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $104.77M | - | |
| Dir | 1.55M | $82.83M | - | |
| Dir | 1.19M | $63.42M | - | |
| CFO | 1.12M | $59.58M | - | |
| VP | 594.7K | $31.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2018 | Garber Alan M50 | Director | Sale+OE | 15,000 | $30.30 | $454,515.00 | -10.9% | |
| Sep 28, 2017 | Hessekiel Jeffrey54 | EVP And General Counsel | Sale+OE | 27,302 | $24.28 | $663,017.80 | -4.8% | |
| Sep 28, 2017 | Schwab Gisela67 | Pres Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $23.79 | $2,378,666.62 | -15.4% | |
| Sep 22, 2017 | Papadopoulos Stelios53 | Director | Sell | 10,000 | $25.40 | $254,000.00 | -100% | |
| Sep 19, 2017 | Papadopoulos Stelios53 | Director | Sell | 200,000 | $27.68 | $5,535,387.30 | -8.3% | |
| Sep 14, 2017 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 60,640 | $27.21 | $1,650,014.40 | -59.3% | |
| Sep 14, 2017 | Morrissey Michael | President And CEO | Sale+OE | 300,000 | $26.90 | $8,071,000.00 | -62.5% | |
| Sep 13, 2017 | Willsey Lance | Director | Sell | 100,000 | $26.88 | $2,688,000.00 | -9.2% | |
| Sep 12, 2017 | Senner Christopher J. | EVP And CFO | Sale+OE | 100,000 | $26.79 | $2,679,000.00 | -49.3% | |
| May 30, 2017 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 5,000 | $18.46 | $92,300.00 | -4.7% |